Rosenblatt cuts Zscaler stock price target on FY27 growth concerns

Rosenblatt cut Zscaler’s price target to $200 from $223 while keeping a Buy rating, citing strong fundamentals but lingering uncertainty around fiscal 2027 core net new annual recurring revenue durability. Zscaler reported remaining performance obligations up about 30% year over year to $6.5 billion, with AI Protect bookings above $100 million and Data Security ARR over $500 million. The stock remains supported by 24% trailing revenue growth and expanding profitability, but multiple analyst target cuts point to mixed sentiment.

Analysis

The key issue is not whether Zscaler is still growing, but whether the market is being asked to underwrite a second acceleration that is increasingly dependent on newer products rather than the core replacement cycle. That usually creates a valuation overhang: investors will pay up for durable subscription compounding, but they will not capitalize “adjacent” AI/security attach at the same multiple until it proves it can drive the numerator, not just diversify the mix. The result is a stock that can look fundamentally healthy while remaining range-bound because the burden of proof shifts from growth to durability.

The more interesting second-order effect is competitive. As customers consolidate around AI security and data security budgets, the winners are likely to be platforms that can bundle policy, identity, and data-layer controls into a single procurement motion. That pressures smaller point solutions and also raises the bar for legacy security vendors that rely on seat expansion alone; if non-seat-based ACV continues to gain mix, the buying center is shifting toward spend tied to workloads and data flows, not headcount. Over 6-18 months, that can re-rate the entire category in favor of infrastructure-like security platforms and away from feature-only vendors.

Near term, the main catalyst path is not earnings upside but guidance credibility. If the company can show that newer product bookings convert into multi-quarter consumption and renewals, the stock can de-rate its “show me” discount quickly; if not, any multiple expansion will be capped by fiscal-2027 skepticism. The downside tail is subtle: if large-customer additions slow even modestly, the market will interpret it as saturation in the enterprise zero-trust base, and the stock can compress hard because expectations are already anchored to future ARR durability rather than present growth.

The contrarian view is that the market may be underestimating how much optionality exists in AI-related security adoption, especially if enterprises decide they need dedicated controls before deploying more internal AI workloads. But the bear case is equally plausible: AI security may be a feature cycle, not a standalone budget line, which would make current optimism too linear. That leaves the setup tactically better for relative-value expressions than outright directional longs at current levels.

Key Decisions for Investors

• Stay underweight ZS on a 1-3 month horizon unless management can re-accelerate forward ARR commentary; upside likely capped in the low-to-mid teens, while a guidance miss could drive a high-single-digit to low-double-digit drawdown.
• Use a call spread on ZS only into a post-guidance reset: buy 6-9 month out-of-the-money calls and sell a higher strike to express upside from AI/security attach without paying full multiple for a stock still in the prove-it phase.
• Pair trade: long ZS vs. a point-solution cybersecurity name with weaker platform breadth over the next 2-4 quarters; the relative winner should be the vendor capturing more non-seat-based budget and data-layer spend.
• If already long ZS, sell upside into strength above prior analyst-target cluster levels and keep a core position only if quarterly large-customer growth stays above mid-teens and newer product ARR remains on a straight-line adoption curve.
• Watch for evidence that AI security bookings convert into renewal-quality revenue over the next 2 earnings cycles; if not, reduce exposure because the market will likely keep discounting fiscal-2027 visibility rather than near-term growth.